Clinical trials
Phase 1 Myelodysplastic Syndromes trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 2 |
| 2007 | 1 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Terminated | 7 |
| Active, not recruiting | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| Mirati Therapeutics Inc. | 2 |
| Pfizer | 2 |
| AbbVie | 1 |
| Amgen | 1 |
| Celgene | 1 |
| Children's Oncology Group | 1 |
| Eli Lilly and Company | 1 |
| Immedica Pharma AB | 1 |
| Incyte Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 21 |
| Leukemia, Myeloid, Acute | 15 |
| Leukemia | 6 |
| Leukemia, Myelomonocytic, Chronic | 4 |
| Myeloproliferative Disorders | 4 |
| Recurrence | 4 |
| Hematologic Neoplasms | 3 |
| Neoplasms | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma, T-Cell | 2 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.